Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase

Qiong Liu, Hao Geng, Changhui Xue, Tomasz (Tom) Beer, Zheng (David) Qian

    Research output: Contribution to journalArticle

    6 Citations (Scopus)

    Abstract

    HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.

    Original languageEnglish (US)
    Pages (from-to)881-891
    Number of pages11
    JournalBiochimica et Biophysica Acta - Molecular Cell Research
    Volume1853
    Issue number5
    DOIs
    StatePublished - May 1 2015

    Fingerprint

    Hypoxia-Inducible Factor 1
    Methyltransferases
    Lysine
    Protein Stability
    Genes
    Response Elements
    Glycolysis
    Small Interfering RNA
    Cell Survival
    Hypoxia
    Neoplasms
    Neoplasm Genes
    Epigenomics
    Oxygen

    Keywords

    • Cancer
    • Gene regulation
    • Hypoxia
    • Metabolic adaptation
    • Protein interaction
    • Transcription factor

    ASJC Scopus subject areas

    • Cell Biology
    • Molecular Biology

    Cite this

    Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase. / Liu, Qiong; Geng, Hao; Xue, Changhui; Beer, Tomasz (Tom); Qian, Zheng (David).

    In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, No. 5, 01.05.2015, p. 881-891.

    Research output: Contribution to journalArticle

    @article{101c1ede5d7f4e9aa33634e4ced004e0,
    title = "Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase",
    abstract = "HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.",
    keywords = "Cancer, Gene regulation, Hypoxia, Metabolic adaptation, Protein interaction, Transcription factor",
    author = "Qiong Liu and Hao Geng and Changhui Xue and Beer, {Tomasz (Tom)} and Qian, {Zheng (David)}",
    year = "2015",
    month = "5",
    day = "1",
    doi = "10.1016/j.bbamcr.2015.01.011",
    language = "English (US)",
    volume = "1853",
    pages = "881--891",
    journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
    issn = "0167-4889",
    publisher = "Elsevier",
    number = "5",

    }

    TY - JOUR

    T1 - Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase

    AU - Liu, Qiong

    AU - Geng, Hao

    AU - Xue, Changhui

    AU - Beer, Tomasz (Tom)

    AU - Qian, Zheng (David)

    PY - 2015/5/1

    Y1 - 2015/5/1

    N2 - HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.

    AB - HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.

    KW - Cancer

    KW - Gene regulation

    KW - Hypoxia

    KW - Metabolic adaptation

    KW - Protein interaction

    KW - Transcription factor

    UR - http://www.scopus.com/inward/record.url?scp=84923103681&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84923103681&partnerID=8YFLogxK

    U2 - 10.1016/j.bbamcr.2015.01.011

    DO - 10.1016/j.bbamcr.2015.01.011

    M3 - Article

    VL - 1853

    SP - 881

    EP - 891

    JO - Biochimica et Biophysica Acta - Molecular Cell Research

    JF - Biochimica et Biophysica Acta - Molecular Cell Research

    SN - 0167-4889

    IS - 5

    ER -